GSA Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $935K | Buy |
|
|||||
|
2025
Q2 | $337K | Sell |
|
|||||
|
2025
Q1 | $3.09M | Buy |
|
|||||
|
2024
Q4 | $528K | Sell |
|
|||||
|
2024
Q3 | $949K | Buy |
|
|||||
|
2024
Q2 | $489K | Buy |
|
|||||
|
2024
Q1 | $439K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $294K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.32M | Buy |
|
|||||
|
2021
Q4 | $219K | Sell |
|
|||||
|
2021
Q3 | $508K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $304K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $266K | Sell |
|
|||||
|
2019
Q3 | $466K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $713K | Sell |
|
|||||
|
2018
Q4 | $1.17M | Sell |
|
|||||
|
2018
Q3 | $1.24M | Buy |
|
|||||
|
2018
Q2 | $360K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.12M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $227K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $427K | Sell |
|
|||||
|
2016
Q3 | $1.22M | Sell |
|
|||||
|
2016
Q2 | $1.55M | Sell |
|
|||||
|
2016
Q1 | $2.95M | Sell |
|
|||||
|
2015
Q4 | $7.05M | Buy |
|
|||||
|
2015
Q3 | $1.55M | Sell |
|
|||||
|
2015
Q2 | $3.38M | Buy |
|
|||||
|
2015
Q1 | $1.61M | Sell |
|
|||||
|
2014
Q4 | $1.52M | Sell |
|
|||||
|
2014
Q3 | $2.65M | Sell |
|
|||||
|
2014
Q2 | $4.41M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $6.69M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $2.4M | Buy |
|